ESR1 and breast carcinoma: We showed the possible association of different DCs subpopulations expressing CD1a, cluster of differentiation 83 (CD83), CD123, DC-LAMP3 and DC-SIGN on their surface along with molecular subtypes of breast carcinoma, estrogen receptor (ER), progesterone receptor (PR) and progression-free survival [11].